Rajeshwar Reddy Kasarla1*, Rahul Reddy Kasarla2 and Sruthi Reddy Thummala3
1Professor and Head, Department of Microbiology, Universal College of Medical Sciences, Bhairahawa, Nepal
2Consultant Orthopaedic Surgeon, Medivison Super Speciality Hospital, Hyderabad, India
3Assistant Professor, Department of Obstetrics & Gynaecology, Gandhi Medical College, Hyderabad, India
*Corresponding Author: Rajeshwar Reddy Kasarla, Professor and Head, Department of Microbiology, Universal College of Medical Sciences, Bhairahawa, Nepal.
Received: September 26, 2022; Published: September 28, 2022
The discovery of hybridoma technology Kohler & Milstein for the production of monoclonal antibodies (1975) revolutionized Medicine and biological sciences by enabling the use of highly specific monoclonal antibodies in basic research, diagnostic applications, and therapeutic molecules. Antibody engineering is a new area of biotechnology which combines molecular biology and recombinant protein production .
Citation: Rajeshwar Reddy Kasarla., et al. “Antibody Engineering".Acta Scientific Biotechnology 3.5 (2022): 31-32.
Copyright: © 2022 Rajeshwar Reddy Kasarla., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.